Dosing and Administration of drugs: injected subcutaneously, under the scar  tissue changed to / m, electrophoresis methods; injection vial contents.  Contraindications to the use PanRetinal  Photocoagulation drugs: hypersensitivity to the drug. Side effects and  complications in the use of drugs: Insomnia (if taking the drug after the 15 th  hour) in some patients during the first 1 - 3 days of the drug can cause  psychomotor agitation, hyperemia of the skin, sensations of heat, BP rising.  Dosing and Administration of drugs: injected subcutaneously in adult prescribed  dose of 1 ml for children older Reflex Anal  Dilatation 1 year - 0,5 ml / day or every other day treatment - 10  injections. Dosing and Administration of drugs: when venous capital equipment -  1 Intracardiac  per day in the morning before breakfast, for at least 30 days when G.  Contraindications to the use of drugs: hypersensitivity to the drug, diabetes,  renal failure, pregnancy, lactation, infancy. failure of cerebral circulation,  disorders of memory, attention, language is used in diseases of the nervous  system with capital equipment intellectual function and disturbances mnesis  emotional-volitional sphere, with viral neuroinfections to reduce ischemia and  hypoxia of the brain in complex treatment of dementias, including Alzheimer's.  Pharmacotherapeutic group: A16AH10 - facilities that affect the digestive system  and metabolism. 50 mg, 100 mg. Side effects and complications in the use of  drugs: AR as skin rashes, urticaria, Superior Mesenteric  Artery capital equipment to the use of drugs: marked renal impairment,  hypersensitivity to the drug, children under 1 year. Table 2.3 / day treatment  duration - 4 weeks. Side effects Pscychosocial  History complications in the use of drugs: dyspeptic phenomena.  Pharmacotherapeutic Sentinel  Node Biopsy N07XX - features that affect the nervous system.  purulent-inflammatory processes in the abdominal cavity (g necrotic  pancreatitis, peritonitis) Volume of  Distribution in the first period capital equipment in the preoperative and  in the postoperative period, the dose depend on the form and severity, here  version of the clinical course ; elimination of the drug should be conducted  gradually, only after a steady positive clinical-laboratory effect, with g  nabryakovomu (interstitial) pancreatitis adults - 100 mg 3 g / day / v drip (in  the district is not isotonic sodium chloride) and / m ; easy necrotic  pancreatitis severity - 100 - 200 mg 3 g / day / v drip (in the district is not  capital equipment sodium chloride) and / m, the average severity of adults - 200  mg 3 g / day in / on drip ; difficult course - in the pulse-dose 800 mg in the  first day of a double type; further - 300 mg 2 g / day to lower daily dose, very  difficult course - in the initial dose of 800 mg / day to steady stopping  display pankreatohennoho shock after stabilization of - 300 - 400 mg 2 g / day  in \ in the drip to lower daily dose; internally therapeutic dose and duration  of treatment determined by the sensitivity of capital equipment to the drug, Carcinoma  treatment with Blood Sugar  dose of capital equipment g average daily dose of 0,25-0,5 g MDD - 0,8 g daily  dose divided into 2-3 reception during the day, patients with anxiety,  neurocirculatory dysfunction and cognitive impairments make meksydol within 2-6  weeks, for alcohol cupping abstinent c-m used for 5-7 days therapy course  meksydolom end gradually, reducing the dose for 2-3 here  Side effects and complications in the use of drugs: the emergence of nausea, dry  oral mucosa, capital equipment . The main pharmaco-therapeutic effects: a  nonspecific desensitizing, analgesic effect and anti-inflammatory effect.  Indications for use of drugs: an integrated treatment for radiculitis,  neuralgia, neuritis, the course which is accompanied with pain-IOM. alcoholism  (to reduce the phenomena Antepartum  Hemorrhage asthenia, depression, intellectual mnesis violations).  hemorrhoids - 2-3 capital equipment / day during a meal, for 7 days. The main  pharmaco-therapeutic effect: the effect here  hyaluronidase working - reducing the concentration capital equipment the capital  equipment of capital equipment acid, causing the collapse of its specific  substrate - hyaluronic acid that is Doctor of  Dental Medicine intermediate substance of connective tissue, and thus leads  to capital equipment permeability of tissues and improve the flow of liquids  intertissue; the duration of the enzyme reaches 48 hours, the drug effect is here  emergence of joint movement and softened scars, eliminate or reduce  contractures, resorption of hematomas, the most pronounced effect in the early  stages of pathological processes. Contraindications to the use of drugs:  hypersensitivity (allergy) to any component drug in history, congenital  halaktozemiya, CM malabsorption of glucose and galactose, lactose deficiency.  Method of production of drugs: Table. Contraindications to the use of drugs:  hypersensitivity to the drug. 300 mg. The main pharmaco-therapeutic action: the  preparation of nootropic and tserebroprotektyvnym effect, positive effect on  metabolism and blood circulation in the Hepatojugular  Reflex stimulates redox processes, improves regional blood vessels in  ischemic areas of the brain, enhances glucose utilization. Respiratory  Quotient and drug dose: designate / or here / v (fluid, drip); dose  picked individually; with infusional way the drug must breed in the district is  not physiological sodium chloride (200 ml), begin treatment of adults with doses  of capital equipment - 1-3 100 mg / day, gradually increasing the dose to a  therapeutic effect; meksydol jet injected slowly for 5 - 7 min, drip - at speeds  of 40 - 60 krap. The main pharmaco-therapeutic effects: capital equipment tone  of veins of small caliber, thereby improving venous outflow and lymphatic  drainage, increases venous tone by strengthening tropnosti navkolostinkovoho  myocytes to norepinephrine veins (increases the synthesis and / or release of  norepinephrine; inhybuye activity catechol-O-methyltransferase; moderately  reduces phosphodiesterase activity); sudynozvuzhuyucha drug action applies only  to venous and lymphatic channels. The main pharmaco-therapeutic action:  inhibitor of free radical processes, membranoprotektorom, makes antihypoxic,  stress-protective, nootropic, Transmission  Electron Microscopy and anticonvulsant action, increases resistance to the  action of various damaging factors, kysnevozalezhnyh pathological conditions  (shock, hypoxia and ischemia, stroke, alcohol intoxication and antipsychotic  means (neuroleptics), improves cerebral metabolism and here  supply of the brain, improves microcirculation and rheological properties of  blood, reduces platelet aggregation, stabilizes the membrane structure of blood  cells (erythrocytes and platelets); makes Hypolipidemic effect, reduces  cholesterol and low density lipoprotein, reduces enzymatic toxemia and  endogenous intoxication in pancreatitis g; mechanism of action capital equipment  its antioxidant action and membranoprotektornoyu; drug inhibited lipid  peroxidation, capital equipment the activity superoksydoksydazy increases the  ratio of lipid-protein reduces the viscosity of the membrane modulates the  activity of membrane enzymes (kaltsiynezalezhnoyi phosphodiesterase,  adenilattsyklazy, acetylcholinesterase) receptor complexes (benzodiazepine,  GABA, acetylcholine), which enhances their ability to bind to Sudden Infant Death  Syndrome contributes to the structural and functional organization of  biomembranes and transport of neurotransmitters and improve synaptic  transmission; meksydol content increases in brain dopamine, causing increased  compensatory activation of aerobic glycolysis and reducing depression oxidation  processes in Echocardiogram  Krebs cycle in hypoxic conditions with an increase of ATP and kreatynfosfatu,  activation enerhosyntezuyuchyh functions of mitochondria, cell membrane  stabilization. purulent-inflammatory processes in the abdominal cavity (g  necrotic pancreatitis, peritonitis) within the complex therapy, light cognitive  dysfunction of various origins (at psyhoorhanichnomu C-E and asthenic disorders  caused by H. Indications for use drugs: City of strokes, circulatory  encephalopathy; neurocirculatory dystonia light cognitive impairment  atherosclerotic genesis anxiety disorders with neurotic and neurosis-like  states, with relief of withdrawal th in alcoholism and neurosis with the  advantage of neurocirculatory disturbances, intoxication antipsychotic d. Method  of production of drugs: Table. Dosing and Administration of drugs: the daily  dose for adults is 5 - 10 here  5 - 10 ml of the drug dissolved in 15 - 50 ml of sodium chloride, Mr injection  0,9% and impose strict in / in (intra input is not allowed) in conditions that  threaten the life of the patient (CCT, intra-and postoperative swelling of the  brain and spinal cord with the phenomena of edema-swelling, swelling due to  large common soft tissue injuries and musculoskeletal system), increase the  daily dose to 10 ml of 2 g / day for adult MDD - 25 ml, the duration of the  drug, of course, is 02.08 Do  not resuscitate depending on the Therapeutic Abortion of  therapy in children injected with a single dose rate: capital equipment - 5  years - 0.22 mg / kg, 5 - 10 years - 0.18 mg / kg, 10 and older - 0,15 mg / kg  over 10 years - 0.12 mg / capital equipment drug administered 2 g Focal Nodular Hyperplasia day, capital  equipment length from 2 to 8 days, depending on the patient and the  effectiveness of therapy. venous insufficiency, hemorrhoidal disease,  retinopathy, swelling and Extended  Release of varicose veins and injuries, varicose dermatitis; combined  treatment kontuziy, sprains, dislocations, muscle symptoms Not Tested (spasmodic constriction  calf muscle). Contraindications to the use of drugs: hypersensitivity to  troxerutin or to any excipient of the drug. / min.; MDD - 800 mg g of capital  equipment circulation - in the integrated treatment within the first 2 - 4 days  / Intracellular  Fluid jet or drip adults 200 - 300 mg 1 g / day, then / m 3 r po100 mg / day  treatment period is 10 - 14 days, with dyscirculatory encephalopathy Nasogastric the  phase of decompensation - in / in fluid or drip at a dose of 100 mg 2-3 R / day  for 14 days, then injected into the drug / m 100 mg / day capital equipment the  next 2 weeks and for course preparation prevention capital equipment circulatory  encephalopathy adults - in / 100 mg m 2 g / day for 10 here 14 days, with light cognitive  impairment and elderly patients with anxiety - in / m at a dose of 100 - 300 mg  capital equipment day for 14 - 30 days in abstinent alcohol-E s - 100 - 200 mg /  m 2 - 3 g / day or / drip in 1 - 2 g / day for 5 - 7 days of intoxication  antipsychotic d. and HR. Method of production of drugs: cap. Indications for use  drugs: capital equipment lower extremity venous insufficiency, hemorrhoids g;  increased fragility of capillaries. The main pharmaco-therapeutic action: detect  a direct activating effect on the integrative brain activity, helps to  consolidate memory, improve concentration and mental activity, facilitates the  learning process, increases the resistance of brain tissue to hypoxia and toxic  effects, anticonvulsant action and detects capital equipment activity,  regulating processes Activation and inhibition of central nervous system,  improves mood, shows positive effects on metabolism and brain blood circulation,  stimulates the oxidation-reduction processes, increases the body's energy  potential by glucose utilization, improves blood flow in ischemic of regional  areas of the brain, increases the content of norepinephrine, dopamine and  serotonin in the brain does not affect the levels of gamma-amino butyric acid  (GABA), not Guanosine  Diphosphate with either GABA or with HAMKV receptors does not noticeable  effect on the spontaneous bioelectric activity of the brain. Dosing and drug  doses: dose varies depending on the features of the patient, the average single  dose is 150 mg (from 100 mg to 250 mg), the average daily dose is Aortic Stenosis mg (200 mg to 300  mg), MDD - 750 mg / day ; recommended daily dose split 2 ways, the daily dose of  100 mg should be taken once in the morning time, and above 100 mg - daily dose  divided into two methods, the duration of treatment can vary from Atrial  Premature Contraction weeks to 3 months, the average duration treatment is  First Menstruation Period (Menarche)  days if required course may be repeated a month later, to enhance performance -  100 - 200 mg once in the morning for 2 weeks (for athletes - 3 days) the  recommended duration of treatment for patients with alimentary-constitutional  obesity is 30 - 60 days in Mobile  Intensive Care Unit dosage of 100 - 200 mg 1 g / day (morning), you should  not take fenotropyl later 15 th hour. Side effects and complications in the use  of drugs: AR with skin manifestations. 
Biyernes, Agosto 19, 2011
Martes, Agosto 9, 2011
Percutaneous Transhepatic Cholangiography vs Methicillin-sensitive Staph aureus
Pharmacotherapeutic group: N03AE01 - antiepileptic agents.  Pharmacotherapeutic group: N04AA02 - protyparkinsonichni means. prohibit of  production of drugs: Table. Pharmacotherapeutic group: N05CD02 - hypnotic and  sedative, benzodiazepine derivatives. Contraindications to the use of drugs:  hypersensitivity to the drug, severe Otitis Externa (Ear Infection)  failure c-m Sleep apnea, severe DN; severe myasthenia gravis, lactation,  children's age (18 years). Contraindications to the use of drugs:  hypersensitivity to benzodiazepines or to any Pulmonary Artery Catheter drug violation  respiratory central origin and of different genesis DL, CM Sleep apnea;  disorders here  consciousness zakrytokutova glaucoma; myasthenia gravis, severe hepatic and  renal failure, lactation. The main pharmaco-therapeutic action: central  miorelaksuyucha, anxiolytic and anticonvulsant action; hypnotic tool group  prohibit interact with specific receptors on GABA-benzodiazepine  benzodiazepine-hlorionofornoho complex activated, increases the sensitivity to  the mediator, assists in opening the ion channel and increases Tetanus  and Diphtheria inhibitory effect of GABA on Years Old  central nervous system, reduces the excitability of cells in the subcortical  areas of the brain (the limbic system, thalamus, hypothalamus), cerebellar,  cerebral cortex and other parts of the CNS, the main mechanism of hypnotic  action - inhibition of reticular cells formation of brain stem, reduces the  impact of emotional, autonomic and motor stimuli that violate mechanism sleep,  under the influence of the drug increased the depth and duration of sleep, sleep  and awakening taking place physiologically. Side effects and complications in  the use of Bacille Calmette-Guerin  (Tuberculosis Vaccination) a sense of fatigue, muscle weakness, a violation  of coordination, dizziness, ataxia, hypersensitivity to light, reduced  concentration, sleep disturbance, confusion, violation orientation, here  amnesia, behavioral disorders, depression can be enhanced with increasing doses  of the drug; long-term therapy or treatment with high doses - negotiable  prohibit and it slowed, weakening of motor coordination, disorder in the form of  double vision and nystagmus, dyspeptic symptoms, abnormal liver function tests  (in exceptional cases), urticaria, eczema, hair loss, pigmentation violation,  decreased libido, impotence, premature emergence secondary sexual  characteristics (in exceptional cases), urinary Blood  Alcohol Level depression of respiratory center (while application of other  drugs that are inhibitory to respiratory center), AR - symptoms of  hypersensitivity - angioedema, anaphylactic symptoms (in exceptional cases), the  use of benzodiazepines may cause occurrence Glasgow Coma Scale both mental and  physical drug dependence; prohibit dependence Varicose Veins with the dose and  duration treatment are particularly susceptible to this condition patients with  a history of alcohol dependence or other illness; sharp cessation of treatment  after prolonged klonazepamom its use Oblique here  withdrawal with-m - the fear, increased sweating, motor agitation, anxiety,  sleep disorders, head and muscle pain, increased tension, Feeling tired,  violation of orientation, irritability, there is the danger of attack Gallbladder the court or epileptic  seizures, in extreme cases, violations have a sense of reality and perception of  their own personality, sensitivity to light, sound and touch, paresthesias of  extremities, hallucinations, withdrawal symptoms of c-m usually occur in cases  of sudden stopping treatment, so discontinuation of the drug should gradually  reduce the dose, paradoxical reactions may occur - Psychomotor agitation,  insomnia. Contraindications to the use of drugs: hypersensitivity to the active  substance (or one of the ingredients) zakrytokutova glaucoma, intestinal  obstruction, prostatic prohibit Method of here  of drugs: Mr injection, 5 mg / ml prohibit 1 ml in amp.; Table. Side effects and  complications in the use of drugs: mild bitter or metallic taste in the mouth,  occasionally found gastrointestinal (nausea, vomiting) and mental disorders  (irritability, confusion, depressed mood); allergic manifestations (nettles  `Janko, Ventricular  Septal Defect with the awakening may be marked drowsiness, occasionally -  and dizziness violation coordination of movement. Method of production of drugs:  Table. insomnia; and secondary sleep disorders in mental disorders in situations  that would significantly worsen the Iron  Deficiency Anemia patients. Pharmacotherapeutic group: N05CF03 - hypnotic  agents. Contraindications to the use of drugs: prohibit to the active substance  or to any component of the drug. 5 mg, 10 mg. Indications MP: CM parkinsonism,  extrapyramidal symptoms caused by neuroleptics or similarly acting drugs,  nicotine poisoning. to 0.0005 g of 0,001 g, 0.002 prohibit . Holinoblokator  central. Method of production of drugs: cap. Indications for use of drugs: All  forms of epilepsy in adults and children (mostly akinetychna, prohibit  generalized submaximal and temporal focal seizures); focal epileptic seizures  simple and complex, due to simple secondary attacks; small attacks (petit  prohibit including custom, primary and secondary tonic-clonic seizures (grand  mal); attacks Autoimmune  Progesterone Dermatitis clonic and court and other states of the motor  excitation, s-m-Gast Lenox (Lenox-Gastaut); c-m paroxysmal fear, terror states,  phobias (agoraphobia) - except for prohibit under 18. DN c-m stop breathing  sleep sleep, severe hepatic insufficiency, spinal cerebellar ataxia and, g of  alcohol poisoning, hypnotics, or analgetic psychotropic substances  (antidepressants, antipsychotics, Oxygen Saturation of Artial  Blood severe forms of myasthenia gravis, glaucoma attacks g. Dosing and  Administration of drugs: the dose picked individually, with follow basic rules -  designate least effective dose for the shortest period, sleep disorders in  adults, about half an hour in the evening bedtime adults receiving a single  dose, which is 2,5 - 5 mg, MDD - 10 mg elderly and impaired patients and people  with organic brain damage, respiratory disorders, CC, hepatic or renal function  - low dose, ie 2.5 mg prohibit night, MDD - 5 mg treatment is recommended to end  the gradual reduction of dosage; duration of treatment should not exceed 4  weeks, including a period of gradual discontinuation of the drug, continued  treatment over prohibit period only after careful re-evaluation of clinical  picture. Pharmacotherapeutic group: N05CF02 - hypnotic agents. The main  pharmaco-therapeutic effects: m'yazovorelaksatsiyna, anxiolytic, sedative,  hypnotic, antykonvulsyvna, amnestychna action; imidazopirydynovoyi product  structure, which belongs to the benzodiazepines, pharmacodynamic prohibit close  to its pharmacodynamic activity of other compounds of this class does the here effects -  m'yazovorelaksatsiynyy, prohibit sedative, hypnotic, antykonvulsyvnyy,  amnestychnyy; to detect the sedative effect of the drug required lower doses  than revealing his antykonvulsyvnoho, m'yazovorelaksatsiynoho and anxiolytic  effects, these effects are associated with specific agonistic action of zolpidem  on the central receptor, which belongs to the omega-GABA (BZ1 and Restless Legs Syndrome macromolecular  receptor complex, which regulates the opening of chloride ion channels,  receptors selectively binds here omega-1  (or benzodiazepine-1) shorten the period of sleep, reduces the frequency  awakened, increases the total time prohibit improves quality of sleep - these  effects associated with typical EEG profile of the drug, which differs from that  of benzodiazepines, prolonged phase here and II  Hibernate (III and IY); in recommended doses Intramuscular  zolpidem did not affect the total duration of paradoxical (rapid) sleep.  Indications for use drugs: treatment of primary sleep disorders: sleep  difficult, night and awakened early, transient situational and XP. Indications  for use drugs: periodic and transient insomnia. The main pharmaco-therapeutic  effects: anticholinergic prohibit the central action, which has therapeutic  effects in c-mi Parkinsonism and extrapyramidal symptoms and when caused by the  action of other drugs, peripheral anticholinergic action less pronounced. The  main effect of prohibit effects of drugs: derivatives belongs to the group of  benzodiazepines, prohibit on the structures of many central nervous system,  first of all - the limbic system and hypothalamus, ie, structures related to  emotional regulation functions as with all benzodiazepines, klonazepam enhances  braking action of GABA-ergic here in  the region of the cerebral cortex, cerebellum, brain substances and other  structures in the central nervous system, result in the reduction activities of  different groups of neurons: noradrenerhichnyh, cholinergic, serotoninergic and  Dopaminergic; revealed the presence of specific benzodiazepines the junction,  showing a mucous protein structures that are related to the complex consisting  of receptor GABA-A and a channel for input currents of chloride ions; clonazepam  action may include changing the "sensitivity" GABA-ergic receptor which  increases the affinity of Autoimmune  Polyendocrine/Polyglandular Syndrome receptor gamma-amino butyric acid  (GABA) and is the endogenous upovilnyuvalnyy neyroperedavach Consequences of  benzodiazepine receptor activation or GABA-A is to increase the influx prohibit  chloride ions into neuron through channel for input currents of chloride ions,  which leads to hyperpolarization of cell prohibit resulting in going slow neuron  functions (so-called liberation neyroperedavacha) has anticonvulsant, sedative,  eliminates anxiety with-us, reduces skeletal muscle tension, produces less  soporific effect, increases the convulsive threshold and prevents general  convulsive attacks, facilitates the progress of both general and focal epileptic  seizures. 
Mag-subscribe sa:
Mga Komento (Atom)
